Piroska Szabó-Révész (P Szabó-Révész)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 23

Top Topics

Pseudomonas Aeruginosa

Chronic Rhinosinusitis

Human Serum Albumin

Top Venues

Drug design, development and therapy

Pharmaceuticals (Basel, Switzerland)

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Petra Party, Márk László Klement, Piroska Szabó-Révész, Rita Ambrus
Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery. Pharmaceutics 15 (2) (2023)
Petra Party, Márk László Klement, Piroska Szabó-Révész, Rita Ambrus
Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery. Pharmaceutics 15 (2) (2023)
Petra Party, Márk László Klement, Piroska Szabó-Révész, Rita Ambrus
Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery. Pharmaceutics 15 (2) (2023)
Petra Party, Márk László Klement, Piroska Szabó-Révész, Rita Ambrus
Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery. Pharmaceutics 15 (2) (2023)
Balázs Attila Kondoros, Orsolya Jójárt-Laczkovich, Ottó Berkesi, Piroska Szabó-Révész, Ildikó Csóka, Rita Ambrus, Zoltán Aigner
Development of Solvent-Free Co-Ground Method to Produce Terbinafine Hydrochloride Cyclodextrin Binary Systems; Structural and In Vitro Characterizations. Pharmaceutics 14 (4) (2022)
Rita Ambrus, Areen Alshweiat, Piroska Szabó-Révész, Csilla Bartos, Ildikó Csóka
Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam. Pharmaceutics 14 (2) (2022)
Gábor Katona, Bence Sipos, Rita Ambrus, Ildikó Csóka, Piroska Szabó-Révész
Characterizing the Drug-Release Enhancement Effect of Surfactants on Megestrol-Acetate-Loaded Granules. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Csilla Bartos, Piroska Szabó-Révész, Tamás Horváth, Patrícia Varga, Rita Ambrus
Comparison of Modern In Vitro Permeability Methods with the Aim of Investigation Nasal Dosage Forms. Pharmaceutics 13 (6) (2021)
Péter Gieszinger, Tamás Kiss, Piroska Szabó-Révész, Rita Ambrus
The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline. Pharmaceutics 13 (6) (2021)
Petra Party, Csilla Bartos, Árpád Farkas, Piroska Szabó-Révész, Rita Ambrus
Formulation and In Vitro and In Silico Characterization of "Nano-in-Micro" Dry Powder Inhalers Containing Meloxicam. Pharmaceutics 13 (2) (2021)
Gábor Katona, Bence Sipos, Mária Budai-Szűcs, György Tibor Balogh, Szilvia Veszelka, Ilona Gróf, Mária A Deli, Balázs Volk, Piroska Szabó-Révész, Ildikó Csóka
Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application. Pharmaceutics 13 (5) (2021)
Csilla Bartos, Patrícia Varga, Piroska Szabó-Révész, Rita Ambrus
Physico-Chemical and In Vitro Characterization of Chitosan-Based Microspheres Intended for Nasal Administration. Pharmaceutics 13 (5) (2021)
Patrícia Varga, Rita Ambrus, Piroska Szabó-Révész, Dávid Kókai, Katalin Burian, Zsolt Bella, Ferenc Fenyvesi, Csilla Bartos
Physico-Chemical, In Vitro and Ex Vivo Characterization of Meloxicam Potassium-Cyclodextrin Nanospheres. Pharmaceutics 13 (11) (2021)
Eszter Nagy, Attila Andrásik, Tamás Smausz, Tibor Ajtai, Fruzsina Kun-Szabó, Judit Kopniczky, Zoltán Bozóki, Piroska Szabó-Révész, Rita Ambrus, Béla Hopp
Fabrication of Submicrometer-Sized Meloxicam Particles Using Femtosecond Laser Ablation in Gas and Liquid Environments. Nanomaterials (Basel, Switzerland) 11 (4) (2021)
Edit Benke, Patrícia Varga, Piroska Szabó-Révész, Rita Ambrus
Stability and In Vitro Aerodynamic Studies of Inhalation Powders Containing Ciprofloxacin Hydrochloride Applying Different DPI Capsule Types. Pharmaceutics 13 (5) (2021)
Luca Éva Uhljar, Sheng Yuan Kan, Norbert Radacsi, Vasileios Koutsos, Piroska Szabó-Révész, Rita Ambrus
In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers. Pharmaceutics 13 (4) (2021)
Ilona Gróf, Alexandra Bocsik, András Harazin, Ana Raquel Santa-Maria, Gaszton Vizsnyiczai, Lilla Barna, Lóránd Kiss, Gabriella Fűr, Zoltán Rakonczay, Rita Ambrus, Piroska Szabó-Révész, Fabien Gosselet, Pongsiri Jaikumpun, Hajnalka Szabó, Ákos Zsembery, Mária A Deli
The Effect of Sodium Bicarbonate, a Beneficial Adjuvant Molecule in Cystic Fibrosis, on Bronchial Epithelial Cells Expressing a Wild-Type or Mutant CFTR Channel. International journal of molecular sciences 21 (11) (2020)
Bence Sipos, Piroska Szabó-Révész, Ildikó Csóka, Edina Pallagi, Dorina Gabriella Dobó, Péter Bélteky, Zoltán Kónya, Ágota Deák, László Janovák, Gábor Katona
Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration. Pharmaceutics 12 (8) (2020)
Rita Ambrus, Péter Gieszinger, Róbert Gáspár, Anita Sztojkov-Ivanov, Eszter Ducza, Árpád Márki, Tamás Janáky, Ferenc Tömösi, Gábor Kecskeméti, Piroska Szabó-Révész, Csilla Bartos
Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity. Molecules (Basel, Switzerland) 25 (5) (2020)
Edit Benke, Árpád Farkas, Piroska Szabó-Révész, Rita Ambrus
Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties. Pharmaceutics 12 (6) (2020)
Csaba Bartos, Rita Ambrus, Gábor Katona, Tamás Sovány, Róbert Gáspár, Árpád Márki, Eszter Ducza, Anita Ivanov, Ferenc Tömösi, Tamás Janáky, Piroska Szabó-Révész
Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia. Drug design, development and therapy 13 (2019)
Aleksandra Gavarić, Jelena Vladić, Rita Ambrus, Stela Jokić, Piroska Szabó-Révész, Milan Tomić, Marijana Blažić, Senka Vidović
Spray Drying of a Subcritical Extract Using Marrubium vulgare as a Method of Choice for Obtaining High Quality Powder. Pharmaceutics 11 (10) (2019)
P Gieszinger, Ioan Tomuţă, T Casian, Cs Bartos, Piroska Szabó-Révész, R Ambrus
Definition and validation of the Design Space for co-milled nasal powder containing nanosized lamotrigine. Drug development and industrial pharmacy 44 (10) (2018)